By Chris Wack
Astrana Health shares fell after the healthcare company reported a surprise fourth-quarter loss.
The stock was down 30%, to $24.31, midday Friday after hitting a three-year low of $23.12 earlier in the session. Shares have lost 44% in the past 12 months.
The Alhambra, Calif., company on Thursday said it had a quarterly loss of $7 million, or 15 cents a share, compared with earnings of $12.4 million, or 26 cents a share, in the same quarter last year. Analysts polled by FactSet were looking for earnings of $5.3 million, or 10 cents a share.
Revenue for the quarter was $665.2 million, compared with last year's $353 million and the $617.2 million analysts were looking for.
For 2025, the company is looking for revenue of $2.5 billion to $2.7 billion, compared with the $2.595 billion analysts are forecasting. The guidance includes $15 million in expected costs associated with continued strategic investments in automation and artificial intelligence, as well as continuing and expected integration costs associated with planned acquisitions. It doesn't include contributions from any acquisitions which haven't yet closed.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
February 28, 2025 13:52 ET (18:52 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。